These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 28710072)

  • 1. Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond.
    Ruiz M; Labarthe F; Fortier A; Bouchard B; Thompson Legault J; Bolduc V; Rigal O; Chen J; Ducharme A; Crawford PA; Tardif JC; Des Rosiers C
    Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H768-H781. PubMed ID: 28710072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure.
    Hunter WG; Kelly JP; McGarrah RW; Khouri MG; Craig D; Haynes C; Ilkayeva O; Stevens RD; Bain JR; Muehlbauer MJ; Newgard CB; Felker GM; Hernandez AF; Velazquez EJ; Kraus WE; Shah SH
    J Am Heart Assoc; 2016 Jul; 5(8):. PubMed ID: 27473038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreases in Circulating Concentrations of Short-Chain Acylcarnitines are Associated with Systolic Function Improvement After Decompensated Heart Failure.
    Chen WS; Liu MH; Cheng ML; Wang CH
    Int Heart J; 2020 Sep; 61(5):1014-1021. PubMed ID: 32879261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure.
    Sabbah HN; Gupta RC; Kohli S; Wang M; Hachem S; Zhang K
    Circ Heart Fail; 2016 Feb; 9(2):e002206. PubMed ID: 26839394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic interactions between peroxisomes and mitochondria with a special focus on acylcarnitine metabolism.
    Houten SM; Wanders RJA; Ranea-Robles P
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165720. PubMed ID: 32057943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy.
    Truby LK; Regan JA; Giamberardino SN; Ilkayeva O; Bain J; Newgard CB; O'Connor CM; Felker GM; Kraus WE; McGarrah RW; Shah SH
    Cardiovasc Diabetol; 2021 Aug; 20(1):161. PubMed ID: 34344360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisomes contribute to the acylcarnitine production when the carnitine shuttle is deficient.
    Violante S; Ijlst L; Te Brinke H; Koster J; Tavares de Almeida I; Wanders RJ; Ventura FV; Houten SM
    Biochim Biophys Acta; 2013 Sep; 1831(9):1467-74. PubMed ID: 23850792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support.
    Ahmad T; Kelly JP; McGarrah RW; Hellkamp AS; Fiuzat M; Testani JM; Wang TS; Verma A; Samsky MD; Donahue MP; Ilkayeva OR; Bowles DE; Patel CB; Milano CA; Rogers JG; Felker GM; O'Connor CM; Shah SH; Kraus WE
    J Am Coll Cardiol; 2016 Jan; 67(3):291-9. PubMed ID: 26796394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased mitochondrial oxidative phosphorylation capacity in the human heart with left ventricular systolic dysfunction.
    Stride N; Larsen S; Hey-Mogensen M; Sander K; Lund JT; Gustafsson F; Køber L; Dela F
    Eur J Heart Fail; 2013 Feb; 15(2):150-7. PubMed ID: 23115323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short communication: Circulating fatty acylcarnitines are elevated in overweight periparturient dairy cows in association with sphingolipid biomarkers of insulin resistance.
    Rico JE; Zang Y; Haughey NJ; Rius AG; McFadden JW
    J Dairy Sci; 2018 Jan; 101(1):812-819. PubMed ID: 29103713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil Treatment in Heart Failure With Preserved Ejection Fraction: Targeted Metabolomic Profiling in the RELAX Trial.
    Wang H; Anstrom K; Ilkayeva O; Muehlbauer MJ; Bain JR; McNulty S; Newgard CB; Kraus WE; Hernandez A; Felker GM; Redfield M; Shah SH
    JAMA Cardiol; 2017 Aug; 2(8):896-901. PubMed ID: 28492915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling of Acylcarnitines in First Episode Psychosis before and after Antipsychotic Treatment.
    Kriisa K; Leppik L; Balõtšev R; Ottas A; Soomets U; Koido K; Volke V; Innos J; Haring L; Vasar E; Zilmer M
    J Proteome Res; 2017 Oct; 16(10):3558-3566. PubMed ID: 28786289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC-MS-based serum fingerprinting reveals significant dysregulation of phospholipids in chronic heart failure.
    Marcinkiewicz-Siemion M; Ciborowski M; Ptaszynska-Kopczynska K; Szpakowicz A; Lisowska A; Jasiewicz M; Waszkiewicz E; Kretowski A; Musial WJ; Kaminski KA
    J Pharm Biomed Anal; 2018 May; 154():354-363. PubMed ID: 29571133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower Concentrations of Circulating Medium and Long-Chain Acylcarnitines Characterize Insulin Resistance in Persons with HIV.
    Bailin SS; Jenkins CA; Petucci C; Culver JA; Shepherd BE; Fessel JP; Hulgan T; Koethe JR
    AIDS Res Hum Retroviruses; 2018 Jun; 34(6):536-543. PubMed ID: 29607651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics.
    Cheng ML; Wang CH; Shiao MS; Liu MH; Huang YY; Huang CY; Mao CT; Lin JF; Ho HY; Yang NI
    J Am Coll Cardiol; 2015 Apr; 65(15):1509-20. PubMed ID: 25881932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure.
    Asselin C; Ducharme A; Ntimbane T; Ruiz M; Fortier A; Guertin MC; Lavoie J; Diaz A; Levy E; Tardif JC; Des Rosiers C
    Redox Biol; 2014; 2():148-55. PubMed ID: 24494189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
    Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
    Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipidomics unveils lipid dyshomeostasis and low circulating plasmalogens as biomarkers in a monogenic mitochondrial disorder.
    Ruiz M; Cuillerier A; Daneault C; Deschênes S; Frayne IR; Bouchard B; Forest A; Legault JT; ; Vaz FM; Rioux JD; Burelle Y; Des Rosiers C
    JCI Insight; 2019 Jul; 4(14):. PubMed ID: 31341105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acid composition in chronic heart failure: low circulating levels of eicosatetraenoic acid and high levels of vaccenic acid are associated with disease severity and mortality.
    Øie E; Ueland T; Dahl CP; Bohov P; Berge C; Yndestad A; Gullestad L; Aukrust P; Berge RK
    J Intern Med; 2011 Sep; 270(3):263-72. PubMed ID: 21466599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive plasma and tissue profiling reveals systemic metabolic alterations in cardiac hypertrophy and failure.
    Müller OJ; Heckmann MB; Ding L; Rapti K; Rangrez AY; Gerken T; Christiansen N; Rennefahrt UEE; Witt H; González Maldonado S; Ternes P; Schwab DM; Ruf T; Hille S; Remes A; Jungmann A; Weis TM; Kreußer JS; Gröne HJ; Backs J; Schatz P; Katus HA; Frey N
    Cardiovasc Res; 2019 Jul; 115(8):1296-1305. PubMed ID: 30418544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.